Journey Medical Corp

DERM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $24.1M $20.3M $27.4M $32.0M $49.1M $8.2M $4.8M
Accounts Receivable $29.8M $10.2M $15.2M $28.2M $23.1M $23.9M
Inventory $9.6M $14.4M $10.2M $14.2M $9.9M $1.4M
Total Current Assets $66.9M $48.2M $56.5M $77.7M $84.5M $35.2M
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill) $27.6M $31.9M $20.3M $27.2M $12.6M $15.0M $7.4M
Total Assets $94.6M $80.2M $76.8M $105.2M $97.3M $51.9M
Liabilities
Accounts Payable $8.9M $16.1M $18.1M $36.6M $22.8M $1.8M
Total Current Liabilities $37.4M $35.2M $41.9M $66.8M $51.6M $28.1M
Long-Term Debt $25.3M $24.9M $14.6M $19.8M
Total Liabilities $62.7M $60.2M $56.5M $88.2M $55.2M $41.6M
Stockholders' Equity
Retained Earnings $-98.5M $-87.0M $-72.4M $-68.5M $-38.9M $5.1M
Total Stockholders' Equity $31.9M $20.1M $20.4M $17.0M $42.0M $10.3M $2.8M